We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOCT icon
8926
Innovator US Small Cap Power Buffer ETF October
KOCT
$136M
$303K ﹤0.01%
+11,697
New +$295K
NGM
8927
CALL
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$303K ﹤0.01%
10,000
-3,200
-24% -$70K
RESE
8928
DELISTED
WisdomTree Emerging Markets ESG Fund
RESE
$303K ﹤0.01%
8,481
-85,386
-91% -$2.84M
PRTK
8929
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$303K ﹤0.01%
+48,540
New +$286K
EXTR icon
8930
CALL
Extreme Networks
EXTR
$3.17B
$302K ﹤0.01%
43,800
+16,300
+59% +$87.5K
NRIX icon
8931
Nurix Therapeutics
NRIX
$2.64B
$302K ﹤0.01%
9,184
-236,016
-96% -$7.82M
VFVA icon
8932
Vanguard US Value Factor ETF
VFVA
$913M
$302K ﹤0.01%
+3,873
New +$276K
FREE
8933
PUT
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$302K ﹤0.01%
+27,700
New +$253K
APTO
8934
PUT
DELISTED
Aptose Biosciences, Inc.
APTO
$302K ﹤0.01%
153
+104
+212% +$244K
Y
8935
PUT
DELISTED
Alleghany Corp
Y
$302K ﹤0.01%
+500
New +$292K
ENIC icon
8936
Enel Chile
ENIC
$6.28B
$301K ﹤0.01%
+77,296
New +$276K
MSA icon
8937
Mine Safety
MSA
$7.49B
$301K ﹤0.01%
+2,016
New +$291K
PPBI
8938
CALL
DELISTED
Pacific Premier Bancorp
PPBI
$301K ﹤0.01%
+9,600
New +$266K
SEM
8939
DELISTED
Select Medical
SEM
$301K ﹤0.01%
20,169
-25,234
-56% -$329K
VBTX
8940
DELISTED
Veritex Holdings
VBTX
$301K ﹤0.01%
+11,725
New +$258K
NTCO
8941
CALL
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$301K ﹤0.01%
+15,060
New +$274K
CEMI
8942
DELISTED
Chembio diagnostics, Inc.
CEMI
$301K ﹤0.01%
63,192
-27,049
-30% -$140K
AVPT icon
8943
AvePoint
AVPT
$2.71B
$300K ﹤0.01%
+20,018
New +$240K
CRAI icon
8944
PUT
CRA International
CRAI
$1.13B
$300K ﹤0.01%
+5,900
New +$265K
EBC icon
8945
PUT
Eastern Bankshares
EBC
$5.25B
$300K ﹤0.01%
+18,400
New +$261K
HBNC icon
8946
Horizon Bancorp
HBNC
$1.05B
$300K ﹤0.01%
18,935
-73,135
-79% -$1M
FGNA.WS
8947
DELISTED
FG New America Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A c
FGNA.WS
$300K ﹤0.01%
+206,636
New +$206K
DBMF icon
8948
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.14B
$299K ﹤0.01%
11,708
-674
-5% -$16.8K
ENSG icon
8949
CALL
The Ensign Group
ENSG
$10.6B
$299K ﹤0.01%
+4,100
New +$272K
HZO icon
8950
MarineMax
HZO
$784M
$299K ﹤0.01%
+8,535
New +$267K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.